{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:04:54Z","timestamp":1776481494761,"version":"3.51.2"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Symptom relief, through adherence to appropriate maintenance therapy, is the sole objective of treatment for patients with endoscopy\u2010negative gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To compare the efficacy of \u2018on\u2010demand\u2019 treatment with esomeprazole 20\u2003mg vs. continuous treatment with lansoprazole 15\u2003mg daily in patients with endoscopy\u2010negative gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Endoscopy\u2010negative gastro\u2010oesophageal reflux disease patients who achieved complete resolution of heartburn after short\u2010term (2\u20134\u2003weeks) treatment with esomeprazole 20\u2003mg (<jats:italic>n<\/jats:italic>\u2003=\u2003774) were randomized to receive either esomeprazole 20\u2003mg on\u2010demand (<jats:italic>n<\/jats:italic>\u2003=311) or lansoprazole 15\u2003mg continuous daily treatment (<jats:italic>n<\/jats:italic>\u2003=\u2003311) for 6\u2003months.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Significantly more patients were willing to continue taking esomeprazole on\u2010demand than lansoprazole continuous therapy after 6\u2003months (93% vs. 88%; <jats:italic>P<\/jats:italic>\u2003=\u20030.02). This superior outcome was achieved despite patients on esomeprazole requiring medication only 38% as often as those on lansoprazole, leading to direct cost savings of more than one\u2010third (36%). Furthermore, patients receiving esomeprazole 20\u2003mg on\u2010demand were more satisfied with their treatment after 1\u2003month compared with patients taking lansoprazole 15\u2003mg continuously.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002In patients with endoscopy\u2010negative gastro\u2010oesophageal reflux disease, esomeprazole 20\u2003mg on\u2010demand is more acceptable to patients and is an economically more effective treatment than lansoprazole 15\u2003mg continuously.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02155.x","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T09:55:08Z","timestamp":1103450108000},"page":"657-665","source":"Crossref","is-referenced-by-count":52,"title":["Esomeprazole 20\u2003mg on\u2010demand is more acceptable to patients than continuous lansoprazole 15\u2003mg in the long\u2010term maintenance of endoscopy\u2010negative gastro\u2010oesophageal reflux patients: the COMMAND Study"],"prefix":"10.1111","volume":"20","author":[{"given":"H. H.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McKeith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vearer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9]]},"reference":[{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200911"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091032"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01423.x"},{"issue":"1","key":"e_1_2_13_5_2","first-page":"S19","article-title":"Non\u2010erosive reflux disease: part of the spectrum of gastro\u2010oesophageal reflux disease, a component of functional dyspepsia, or both","volume":"13","author":"Quigley EMM.","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.17.s2.5.x"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00008"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2008.S1"},{"key":"e_1_2_13_10_2","first-page":"451","article-title":"Long\u2010term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin APS","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00813.x"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01464.x"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90036-1"},{"key":"e_1_2_13_14_2","first-page":"A230","article-title":"Predictors of treatment response in patients with non\u2010erosive reflux disease (NERD)","volume":"51","author":"Talley NJ","year":"2002","journal-title":"Gut"},{"key":"e_1_2_13_15_2","first-page":"463","article-title":"Factors influencing compliance in long\u2010term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin APS","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_13_16_2","unstructured":"Zoton 15\u2003mg\/30\u2003mg Capsules Summary of Product Characteristics (SmPC). September2001."},{"issue":"1","key":"e_1_2_13_17_2","article-title":"Alternative day and prn lansoprazole in the maintenance treatment of oesophagitis","volume":"42","author":"Roseveare C","year":"1998","journal-title":"Gut"},{"issue":"1","key":"e_1_2_13_18_2","first-page":"17","article-title":"Efficacy and tolerability of lansoprazole 15\u2003mg as maintenance therapy of GORD","volume":"7","author":"Baldi F","year":"2000","journal-title":"Dis Manage Health Outcomes"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03022115"},{"key":"e_1_2_13_20_2","unstructured":"Nexium 20\u2003mg\/40\u2003mg Tablets Summary of Product Characterisics (SmPC). July2000."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02155.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02155.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:29:41Z","timestamp":1697232581000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02155.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02155.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02155.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}